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         ABSTRACT 
Colorectal tumors are responsible for more than 600 000 deaths per year worldwide and 
thereby constitute the second most common cause of cancer related mortality. Early detection 
is related to improved prognosis and identification of genetic biomarkers would meliorate 
available diagnostic tools. Existing tumor classification systems lack precise monitoring 
within individual tumor stages in relation to progression. Therefore, we performed genetic 
characterization of tumor progression by analyses of colorectal tumors and normal colon 
mucosa.  We used combined microarray analysis to obtain a set of candidate biomarkers, 
starting with genome-wide DNA analyses to screen for tumor-specific aberrant DNA patterns 
followed by correlations to the associated changes in mRNA and microRNA expression. We 
also investigated the relation between functional p53 and tumor progression as well as 
survival in patients with colorectal cancer (CRC). Furthermore, we used high resolution 
oligonucleotide array based CGH to identify nonpolymorphic structural variation in DNA 
from normal colon biopsies from patients with confirmed CRC to reveal candidate regions 
with association to putative familial CRC genetic variants.  
Colorectal tumor progression is proposed to follow a step-wise transformation from 
normal cells into malignant tumors, and therefore we used different stages within this model 
to summarize our results, in terms of genetic events of potential importance. First, gain in 
parts of chromosome 20 encompassing AURKA, as well as alterations in p53 (17p13.1), may 
be involved in the development from adenoma to carcinoma. Second, loss of 18q and gain of 
8q harboring SMAD7 and PTP4A3 appear to rise during progression defined as early (Dukes 
A and B) to late (Dukes C and D) tumor stage. Third, distant metastatic potential may be 
associated to loss of 8p and increased expression of miR-373. Fourth, putative structural 
variants observed in normal colon mucosa may predispose for the onset of malignant 
transformation in familial sporadic CRC. Finally, there is a clear relationship between 
increased properties of aberrant DNA content as well as the number of combined genetic 
events and tumor progression.       
We conclude that correlated changes in DNA and RNA abundance may represent a 
robust rationale for selection of genetic biomarkers. Moreover, our results also suggest that 
Dukes D tumors possibly develop in a way that does not fit into the stepwise progression 
model, illustrated by earlier onset and less genetic aberrations.  These results represent a set 
of genetic events that can hopefully contribute to improved procedures considering diagnosis 
and prognosis in CRC patients by providing genetic biomarkers.   
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